Biosynthesis of alpha fetoprotein by MCF-7 human breast cancer cells
- 15 March 1985
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 35 (3) , 315-318
- https://doi.org/10.1002/ijc.2910350306
Abstract
Direct evidence was obtained for de novo synthesis of AFP by MCF‐7 human breast cancer cells per se. Synthesis was demonstrated by L‐14C‐leucine and L‐35S‐methionine incorporation into immunochemically isolated AFP, and confirmed by radioimmunodiffusion and radioimmunoelectrophoresis. This information indicates that AFP synthesis is associated with normal and neoplastic cells of several different histotypes, and suggests that AFP detected and measured previously in primary human breast cancer tissue cytosol (Sarcione et al., 1983) also resulted from in situ biosynthesis by breast cancer cells per se rather than uptake of exogenous AFP originating from extracellular sources. Evidence that AFP obtained after treatment of 14C‐leucine radiolabelled MCF‐7 breast cancer cell protein with 0.4 M KC1 contained 2.6 times more radioactivity than did AFP obtained before such salt treatment is interpreted as indicating that two different molecular species of de novo synthesized AFP existed in breast cancer cells: (1) larger amount of non‐immunoreactive AFP which became immunoreactive and measurable after KC1 treatment, and (2) smaller amounts of free immunoreactive AFP. 14C‐radiolabelled AFP obtained before and after treatment of cell protein with 0.4 M KC1 codiffused, comigrated with alpha, electrophoretic mobility and gave an identical radioimmunologic reaction both with each other and with added carrier human cord serum AFP. Furthermore, preliminary studies indicated that radiolabelled non‐immunoreactive AFP could be separated from lower‐molecular‐weight free AFP by chromatography on Sephadex G‐200. Taken together, these findings suggest that synthesized free AFP was bound as a non‐immunoreactive high‐molecular‐weight macromolecular complex rather than being covalently linked. Our current working hypothesis is that most of the de novo synthesized endogenous AFP in MCF‐7 human breast cancer cells was rapidly and reversibly bound by hydrophobic bonding to a specific cytoplasmic AFP‐receptor.Keywords
This publication has 13 references indexed in Scilit:
- Alpha-fetoprotein receptors in a human breast cancer cell lineBiochemical and Biophysical Research Communications, 1984
- Control of growth of estrogen-sensitive cells: role for alpha-fetoprotein.Proceedings of the National Academy of Sciences, 1980
- But … Are Estrogens Per Se Growth-Promoting Hormones?4JNCI Journal of the National Cancer Institute, 1980
- Synthesis of alpha fetoprotein by immature rat uterusBiochemical and Biophysical Research Communications, 1980
- AlphafetoproteinPublished by Springer Nature ,1980
- Estrogen Receptor and Alpha-Fetoprotein in Human Breast Cancer: Brief Communication 2JNCI Journal of the National Cancer Institute, 1978
- Alpha-fetoprotein: the major high-affinity estrogen binder in rat uterine cytosols.Proceedings of the National Academy of Sciences, 1976
- The use of a radioimmunoassay for alpha-fetoprotein in the diagnosis of malignancyCancer, 1974
- Alpha-Fetoprotein in Ontogenesis and its Association with Malignant TumorsAdvances in Cancer Research, 1971